Actinium Pharmaceuticals Inc ATNM Income Statements

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
AMEX
Actinium Pharmaceuticals Inc (ATNM)
Actinium Pharmaceuticals Inc (ATNM) Financials

Actinium Pharmaceuticals Inc (ATNM)

1.44

0.03

(2.13%)

Closed November 28 3:00PM

Delayed by 15 minutes

1.43

-0.01

(-0.69%)

After Hours: 6:59PM

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Annual Quarterly

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	45k	45k	0	0	0	0	81k	0
Operating Income	-7.85M	-9.8M	-11.29M	-11.58M	-15.64M	-14.35M	-10.34M	-9.6M
Pre Tax Income	-7.77M	-9.47M	-10.65M	-11.04M	-15.18M	-13.28M	-9.32M	-8.67M
Net Income	-7.77M	-9.47M	-10.65M	-11.04M	-15.18M	-13.28M	-9.32M	-8.67M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	0	0	0	0	0	0	0	0
EBIT	-7.85M	-9.8M	-11.29M	-11.58M	-15.64M	-14.35M	-10.34M	-9.6M
EBITDA	-7.67M	-9.58M	-11.13M	-11.4M	-15.43M	-14.15M	-10.14M	-9.38M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	0	0	0	0	0	1.14M	1.03M	81k
Operating Income	-26.85M	-26.91M	-23.83M	-22.07M	-22.39M	-24.96M	-34.1M	-51.92M
Pre Tax Income	-24.32M	-26.6M	-23.65M	-21.9M	-22.22M	-24.77M	-33.02M	-48.82M
Net Income	-24.32M	-26.6M	-23.65M	-21.9M	-22.22M	-24.77M	-33.02M	-48.82M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	-0.436	-0.332	-0.204	-0.133	-1.154	-1.204	-1.286	-1.781
EBIT	-26.85M	-26.91M	-23.83M	-22.07M	-22.39M	-24.96M	-34.1M	-51.92M
EBITDA	-26.77M	-26.85M	-23.78M	-22.02M	-21.95M	-24.44M	-33.41M	-51.13M

Actinium Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions